SCHEMBL6410853

SCHEMBL6410853

CCOC(=O)ON1CCC(NC(=O)C2=NOC3(CCN(C(=O)c4ccc(F)cc4F)CC3)C2)CC1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.41
HSD17B10 Q99714 4/20 0.40
DRD2 P14416 1/20 0.40
DRD3 P35462 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 3/20 0.39
GAA P10253 2/20 0.38
GPR119 Q8TDV5 1/20 0.38
ALDH1A1 P00352 3/20 0.38
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
ACKR3 P25106 1/20 0.37
MAPK1 P28482 2/20 0.37
RAB9A P51151 1/20 0.37
DPP4 P27487 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2399891 0.92 SMN1; SMN2 (0.49) SMN1; SMN2HSD17B10DRD2DRD3MEN1
SCHEMBL6411301 0.83 SMN1; SMN2 (0.37) SMN1; SMN2HSD17B10KDM4EALDH1A1LMNA
SCHEMBL6411672 0.81 L3MBTL1 (0.37) SMN1; SMN2HSD17B10MEN1KMT2AKDM4E
SCHEMBL6409543 0.78 HRH3 (0.39) SMN1; SMN2HSD17B10MEN1KMT2AKDM4E
SCHEMBL6410200 0.75 KDM4E (0.44) SMN1; SMN2HSD17B10KMT2AKDM4EGAA
SCHEMBL6411501 0.75 KDM4E (0.48) SMN1; SMN2MEN1KMT2AKDM4EGPR119
SCHEMBL2400257 0.74 PLG (0.45) SMN1; SMN2HSD17B10MEN1KMT2AKDM4E
SCHEMBL2403190 0.74 HPGD (0.46) MEN1KMT2AKDM4EGAAALDH1A1
SCHEMBL6412521 0.73 EPHX2 (0.47) SMN1; SMN2HSD17B10KDM4EGAAALDH1A1
SCHEMBL2402983 0.71 L3MBTL1 (0.46) SMN1; SMN2HSD17B10MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401841-B1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN GRUENENTHAL GMBH (DE) 2005-08-24 EP claimed
EP-1401841-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2004-03-31 EP claimed
WO-2003000699-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO[4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2003-01-03 WO claimed
EP-1401841-B1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN GRUENENTHAL GMBH (DE) 2005-08-24 EP disclosed
EP-1401841-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2004-03-31 EP disclosed
WO-2003000699-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO[4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2003-01-03 WO disclosed